Select Medical (NYSE:SEM) Updates FY 2019 Earnings Guidance

Select Medical (NYSE:SEM) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided earnings per share guidance of $0.97-1.13 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.05. The company issued revenue guidance of $5.2-5.4 billion, compared to the consensus revenue estimate of $5.32 billion.Select Medical also updated its FY19 guidance to $0.97-1.13 EPS.

Shares of NYSE:SEM traded down $0.73 during midday trading on Friday, hitting $15.78. 850,074 shares of the stock were exchanged, compared to its average volume of 543,002. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 4.46. Select Medical has a 52-week low of $12.96 and a 52-week high of $20.80. The stock’s fifty day moving average is $15.82. The company has a market cap of $2.27 billion, a P/E ratio of 15.32, a PEG ratio of 1.11 and a beta of 1.27.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, August 1st. The health services provider reported $0.33 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.33. Select Medical had a return on equity of 14.26% and a net margin of 2.80%. The business had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.34 billion. During the same period last year, the company earned $0.31 earnings per share. Select Medical’s quarterly revenue was up 5.0% compared to the same quarter last year. On average, analysts anticipate that Select Medical will post 1.08 EPS for the current fiscal year.

Several analysts recently issued reports on SEM shares. TheStreet upgraded Select Medical from a c+ rating to a b- rating in a report on Thursday, June 27th. JMP Securities upgraded Select Medical from a market perform rating to an outperform rating and set a $18.00 price objective for the company in a report on Friday, May 17th. ValuEngine upgraded Select Medical from a sell rating to a hold rating in a report on Wednesday, May 22nd. Finally, Barclays reiterated a hold rating and set a $16.00 price objective on shares of Select Medical in a report on Thursday, May 9th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The stock has an average rating of Hold and an average target price of $16.67.

About Select Medical

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

See Also: Current Ratio

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with's FREE daily email newsletter.